8th Nov 2005 15:00
Skyepharma PLC08 November 2005 For Immediate Release 8 November 2005 SkyePharma PLC SKYEPHARMA TO PRESENT AT THE SG COWEN & CO 6th ANNUAL GLOBAL HEALTH CARE CONFERENCE IN BARCELONA LONDON, UK, 8 November 2005 -- SkyePharma PLC (LSE: SKP; Nasdaq: SKYE) announcestoday that the Company's Chief Executive, Michael Ashton, will make apresentation at the SG Cowen & Co. 6th Annual Global Health Care Conference atthe Hilton Diagonal Mar Hotel in Barcelona, Spain. Mr. Ashton will deliver hispresentation on Thursday, November 10, 2005 at 10.55 a.m. (CET). Investors mayaccess a live webcast of the presentation at www.skyepharma.com under theInvestor Relations tab. About SkyePharma PLC SkyePharma PLC uses its world-leading drug delivery technology to developeasier-to-use and more effective formulations of drugs. The majority ofchallenges faced in the formulation and delivery of drugs can be addressed byone of the Company's proprietary technologies in the areas of oral, injectable,inhaled and topical delivery, supported by advanced solubilisation capabilities.For more information, visit www.skyepharma.com. For further information please contact: SkyePharma PLC +44 207 491 1777Michael Ashton, Chief Executive OfficerPeter Laing, Director of Corporate Communications 44 207 491 5124Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court / Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L